About Bethyl Laboratories
Founded in 1972, Bethyl Laboratories develops and manufactures antibodies, antigens and immunodetection reagents for life science research, diagnostics and assay development. Originally established as a family-owned company and now part of Fortis Life Sciences, Bethyl is recognised for its rigorous antibody validation approach designed to support reproducible and reliable experimental results. Its scientific expertise spans antibody discovery, production and characterisation, with capabilities including monoclonal, polyclonal and recombinant antibody development. Bethyl products are used across immunology, oncology, neuroscience, cardiovascular research and molecular biology, supporting applications such as western blotting, immunohistochemistry, immunocytochemistry, ELISA, chromatin immunoprecipitation and flow cytometry.
The company’s portfolio includes primary and secondary antibodies, purified proteins, antibody conjugates, antigens and reagents for clinical diagnostic assay development. A key feature of its workflow is the proprietary Six-Pillar Validation methodology, which uses multiple complementary approaches to assess antibody specificity and performance across different applications. In addition to catalogue products, Bethyl Laboratories provides custom antibody development, VHH antibody discovery, antibody conjugation and spatial biology services for research and diagnostic programmes.
Europa Biosite’s subsidiaries distribute for Bethyl Laboratories in Austria, Belgium, Denmark, Estonia, Finland, Germany, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Sweden, Switzerland and the United Kingdom.